The second generation of GenomEra SARS-CoV-2 2.0 Assay Kit takes the usability and sensitivity to a new level. The assay provides fast and reliable detection of SARS-CoV-2 using RT-PCR, the golden standard for COVID-19 diagnostics. The easy-to-use GenomEra platform combines the simplicity of rapid testing and the superior sensitivity of PCR methods in one reliable system.
The GenomEra SARS-CoV-2 2.0 is a rapid and highly sensitive multiplex RT-qPCR test for the detection of SARS-CoV-2 from respiratory samples. Only a short and simple sample preparation is needed, after which the assay is fully automated and the qualitative result will be automatically interpreted with Ct values after 50 minutes. Due to the simplicity of the system, no prior experience in PCR nor dedicated PCR facilities are required.
The assay is compatible with a wide range of commercial sample collection media available, including inactivating media. If the sample is collected to an inactivating media, it allows safe handling of the sample without the need for extensive biosafety measures and minimizes the hands-on time. Additionally, the new assay includes an integrated sample processing control targeting a specific human housekeeping gene mRNA.
- Rapid PCR test results with excellent sensitivity (98.3%) and high specificity (99.8%)
- No extensive safety measures nor dedicated PCR facilities are required
- Only a short and simple sample preparation is needed, after which the assay is fully automated
- Test result is automatically interpreted as positive, negative or borderline with Ct values in just 50 minutes
Download GenomEra SARS-CoV-2 2.0 Brochure
Download GenomEra SARS-CoV-2 2.0 Quick Guide